INAB
Income statement / Annual
Last year (2023), IN8bio, Inc.'s total revenue was $0.00,
and the percentage change from the previous year is not available.
In 2023, IN8bio, Inc.'s net income was -$30.01 M.
See IN8bio, Inc.’s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
| Period Ended |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
| Operating Revenue |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Cost of Revenue |
$2.50 M |
$1.10 M |
$251,000.00 |
$96,000.00 |
$96,000.00 |
$96,000.00 |
| Gross Profit |
-$2.50 M |
-$1.10 M |
-$251,000.00 |
-$96,000.00 |
-$96,000.00 |
-$96,000.00 |
| Gross Profit Ratio |
0 |
0 |
0 |
0 |
0 |
0 |
| Research and Development
Expenses |
$16.83 M
|
$14.06 M
|
$7.35 M
|
$5.38 M
|
$2.36 M
|
$581,000.00
|
| General & Administrative
Expenses |
$13.51 M
|
$14.46 M
|
$7.31 M
|
$3.18 M
|
$2.71 M
|
$1.42 M
|
| Selling & Marketing
Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General &
Administrative Expenses |
$13.51 M
|
$14.46 M
|
$7.31 M
|
$3.18 M
|
$2.71 M
|
$1.42 M
|
| Other Expenses |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
-$63,000.00 |
| Operating Expenses |
$30.34 M |
$28.52 M |
$14.65 M |
$8.56 M |
$5.07 M |
$2.00 M |
| Cost And Expenses |
$30.34 M |
$28.52 M |
$14.65 M |
$8.56 M |
$5.07 M |
$2.00 M |
| Interest Income |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
| Interest Expense |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$14,000.00 |
| Depreciation &
Amortization |
$1.83 M
|
$1.10 M
|
$251,000.00
|
$96,000.00
|
$96,000.00
|
$96,000.00
|
| EBITDA |
-$28.50 M
|
-$27.42 M
|
-$14.40 M
|
-$8.47 M
|
-$5.04 M
|
-$1.97 M
|
| EBITDA Ratio |
0 |
0 |
0 |
0 |
0 |
0 |
| Operating Income Ratio
|
0
|
0
|
0
|
0
|
0
|
0
|
| Total Other
Income/Expenses Net |
$330,000.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
-$77,000.00
|
| Income Before Tax |
-$30.01 M |
-$28.52 M |
-$14.65 M |
-$8.56 M |
-$5.13 M |
-$2.08 M |
| Income Before Tax Ratio
|
0
|
0
|
0
|
0
|
0
|
0
|
| Income Tax Expense |
$0.00 |
-$1.10 M |
$551,442.00 |
-$118,297.00 |
-$68,000.00 |
-$63,000.00 |
| Net Income |
-$30.01 M |
-$27.42 M |
-$14.65 M |
-$8.56 M |
-$5.13 M |
-$2.08 M |
| Net Income Ratio |
0 |
0 |
0 |
0 |
0 |
0 |
| EPS |
-1 |
-1.31 |
-0.78 |
-0.44 |
-0.27 |
-0.34 |
| EPS Diluted |
-1 |
-1.31 |
-0.78 |
-0.44 |
-0.27 |
-0.34 |
| Weighted Average Shares
Out |
$29.86 M
|
$20.97 M
|
$18.78 M
|
$19.35 M
|
$19.35 M
|
$6.17 M
|
| Weighted Average Shares
Out Diluted |
$29.86 M
|
$20.97 M
|
$18.78 M
|
$19.35 M
|
$19.35 M
|
$6.17 M
|
| Link |
|
|
|
|
|
|
